Skip to main content
. 2020 Jul 15;11:446. doi: 10.3389/fendo.2020.00446

Figure 5.

Figure 5

Effects of ethacridine on TAZ in human iPSCs (LF cells). (A) Enhancement of TAZ in ethacridine treated activin A derived endoderm from human iPSCs (LF cells). Data were expressed as mean ± SEM and represent one of three separate experiments. **p < 0.01 ethacridine treated activin A derived endoderm in comparison with untreated or activin A treated alone. Data were analyzed by analysis of variance (ANOVA) followed by the Student-Newman-Keuls test. (B) The relative abundances of TAZ in cells in cytoplasm and nucleus was quantified from sets of 10 cells per image and expressed as arbitrary units of Fluorescence Intensity (FI). Data are means ± SEM of three independent experiments. **P < 0.01 comparison among different groups. Data were analyzed by analysis of variance (ANOVA) followed by the Student-Newman-Keuls test.